#USA #New Orleans #vascular surgery #MolecuLight #Wound Imaging

MolecuLight Showcases Innovative Wound Imaging Platform at SVS VAM 2025

MolecuLight Inc., a leader in point-of-care fluorescence imaging technology, is set to make headlines at the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM) 2025. This prestigious event, taking place from June 4 to 7 in New Orleans, Louisiana, will be the venue for MolecuLight to present its advanced wound imaging solutions.

Leading the Charge in Wound Care

The company will showcase its DX™ device at booth #654, designed to provide clinicians with real-time insights into wound conditions. This includes the detection of infection-causing bacteria, accurate digital wound measurement, and an innovative thermal imaging feature to visualize temperature changes in wounds. These capabilities are crucial for clinicians striving to enhance patient outcomes through informed treatment decisions.

MolecuLight’s technology aligns perfectly with the SVS mission to promote advancements in vascular medicine. By furnishing objective, evidence-based data, it empowers healthcare professionals to make better-informed decisions right at the point of care.

Recognition and Award Winning Research

A significant highlight of this year's meeting will be the presentation by Dr. Alisha Oropallo, who has been awarded the Society for Vascular Surgery Section on Ambulatory Vascular Care (SAVC) Presentation Award. Her research titled “An objective comparative study of non-surgical cleansing techniques and cleanser types in bacterial burden management” will shed light on the importance of objective assessment in wound care. Dr. Oropallo's work emphasizes the critical need for empirical data in managing bacterial infection in wounds, a focus that resonates with MolecuLight's mission.

Anil Amlani, the CEO of MolecuLight, expressed enthusiasm about participating in this key event and acknowledged Dr. Oropallo's achievement: “We are delighted to be part of the SVS Vascular Annual Meeting and to engage with leading vascular surgeons. Congratulations to Dr. Oropallo on her well-deserved recognition. We are proud that her research, underscoring the critical need for objective data in wound care, will be showcased at this esteemed meeting.”

Join Us

Attendees of the SVS Vascular Annual Meeting are encouraged to visit MolecuLight at booth #654. This is a perfect opportunity to explore how the DX™ device can enhance clinical practice efficiency and improve patient care outcomes through innovative imaging solutions.

In the fast-evolving landscape of wound management, technologies like MolecuLight's are not just favorable but essential. As more healthcare professionals seek both reliable and rapid assessments, solutions that integrate advanced imaging with actionable insights will continue to gain prominence in improving wound care strategies.

For those looking to elevate their wound management protocols, MolecuLight stands ready to provide the necessary tools and support.